Recombinant Factor VIIa for Intracerebral Hemorrhage "NovoSeven - Pilot"

Completed

Phase N/A Results

Summary of Purpose

To evaluate the safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 January 2005.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • NovoNordisk

Trial Design

Randomized, placebo-controlled, dose-escalation, pilot study.

Contacts

Not available